Technical Analysis for SPRY - ARS Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 8.35 | 3.21% | 0.26 |
SPRY closed up 3.21 percent on Friday, April 26, 2024, on 66 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 13
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Lizard Bullish | Bullish Day Trade Setup | 3.21% | |
| Doji - Bullish? | Reversal | 3.21% | |
| Gapped Down | Weakness | 3.21% | |
| Lower Bollinger Band Touch | Weakness | 3.21% | |
| Oversold Stochastic | Weakness | 3.21% | |
| NR7 | Range Contraction | 1.09% | |
| Oversold Stochastic | Weakness | 1.09% | |
| 50 DMA Resistance | Bearish | -1.76% |
| Alert | Time |
|---|---|
| 10 DMA Resistance | about 20 hours ago |
| 60 Minute Opening Range Breakout | about 21 hours ago |
| Rose Above 10 DMA | about 21 hours ago |
| Up 1 ATR | about 21 hours ago |
| Up 5% | about 21 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
ARS Pharmaceuticals, Inc. develops ARS-1, a novel intranasal epinephrine spray with absorption technology for patients and their families at-risk of severe allergic reactions to food, medications, and insect bites. Its product includes Neffy, a low-dose intranasal epinephrine nasal spray. The company was incorporated in 2015 and is based in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Allergy Respiratory Therapy Respiratory Diseases Type I Hypersensitivity Allergology Nasal Administration Anaphylaxis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Allergy Respiratory Therapy Respiratory Diseases Type I Hypersensitivity Allergology Nasal Administration Anaphylaxis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.27 |
| 52 Week Low | 2.55 |
| Average Volume | 788,442 |
| 200-Day Moving Average | 6.40 |
| 50-Day Moving Average | 8.81 |
| 20-Day Moving Average | 9.01 |
| 10-Day Moving Average | 8.58 |
| Average True Range | 0.52 |
| RSI (14) | 43.18 |
| ADX | 22.35 |
| +DI | 23.44 |
| -DI | 26.83 |
| Chandelier Exit (Long, 3 ATRs) | 9.72 |
| Chandelier Exit (Short, 3 ATRs) | 9.21 |
| Upper Bollinger Bands | 10.10 |
| Lower Bollinger Band | 7.92 |
| Percent B (%b) | 0.2 |
| BandWidth | 24.25 |
| MACD Line | -0.18 |
| MACD Signal Line | -0.03 |
| MACD Histogram | -0.1515 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.19 | ||||
| Resistance 3 (R3) | 9.20 | 8.93 | 9.05 | ||
| Resistance 2 (R2) | 8.93 | 8.72 | 8.93 | 9.00 | |
| Resistance 1 (R1) | 8.64 | 8.58 | 8.79 | 8.63 | 8.96 |
| Pivot Point | 8.37 | 8.37 | 8.44 | 8.37 | 8.37 |
| Support 1 (S1) | 8.08 | 8.16 | 8.23 | 8.07 | 7.74 |
| Support 2 (S2) | 7.81 | 8.02 | 7.81 | 7.70 | |
| Support 3 (S3) | 7.52 | 7.81 | 7.65 | ||
| Support 4 (S4) | 7.51 |
